Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

NHS boss promises major shift in culture to promote innovation

NHS reforms NHS chief executive Sir David Nicholson has urged healthcare workers to make innovation a priority, stressing that it should become "everybody's job" from top to bottom in the NHS.

NHS chief executive Sir David Nicholson has urged healthcare workers to make innovation a priority, stressing that it should become "everybody's job" from top to bottom in the NHS.

"We should bring about a major shift in culture within the NHS, and develop our people by hardwiring innovation into training and education for managers and clinicians," Mr Nicholson said as the government unveiled a support package designed to promote innovation in healthcare. "Put simply, we must make innovation a priority."

Under government plans, clinical commissioning groups in the new NHS will be put under a duty to seek out and adopt best practice and promote innovation. NHS training and education programs will also be introduced to promote the new ethos that Mr Nicholson hopes will help the NHS meet its planned £20 billion efficiency savings.

The new plans, which were first outlined by David Cameron on Monday, include a range of proposals and funding packages designed to support innovation in medical research and health services.

Alongside plans to open up access to public data sets including health data on prescribing, one of the proposals announced was a NICE compliance regime designed to ensure the treatment regimes it recommends are adopted locally. Many local health authorities opt not to fund some NICE-recommended drugs because of their high costs.

The government has not yet given details on its plan for the compliance regime, but the work will be overseen by the new NHS Commissioning Board.

Association of the British Pharmaceutical Industry chief executive Stephen Whitehead said: "The proposals outlined by government will contribute towards patients receiving better treatments, more quickly and build the UK's attractiveness as a leading hub for medical and health research."

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD014825

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel